E-LIB Suche - Ergebnisse für: Monkhorst, Kim - Sprache DE

Sortierung: Relevanz

Sortierung: Jahr

1

Identification of protein biomarkers for prediction of resp..:

Böttger, Franziska ; Radonic, Teodora ; Bahce, Idris...
Molecular Oncology. 18 (2024) 6 - p. 1417-1436 , 2024

Link: https://doi.org/10.1002/..

2

ROS1 fusions in resected stage I-III adenocarcinoma: Result..:

Speel, Ernst-Jan M. ; Dafni, Urania ; Thunnissen, Erik...
Lung Cancer. , 2024

Link: https://doi.org/10.1016/..

3

Blood platelet RNA profiles do not enable for nivolumab res..:

Muller, Mirte ; Best, Myron G. ; van der Noort, Vincent...
Tumor Biology. 46 (2024) s1 - p. S327-S340 , 2024

Link: https://doi.org/10.3233/..

4

Combining Genomic Biomarkers to Guide Immunotherapy in Non–..:

van de Haar, Joris ; Mankor, Joanne M. ; Hummelink, Karlijn...
Clinical Cancer Research. 30 (2024) 7 - p. 1307-1318 , 2024

Link: https://doi.org/10.1158/..

5

Impact of genetic counseling strategy on diagnostic yield a..:

Koster, Roelof ; Schipper, Luuk J. ; Giesbertz, Noor A.A....
Genetics in Medicine. 26 (2024) 2 - p. 101032 , 2024

Link: https://doi.org/10.1016/..

6

Elucidating the Heterogeneity of Immunotherapy Response and..:

Murray, Joseph C. ; Sivapalan, Lavanya ; Hummelink, Karlijn...
Clinical Cancer Research. 30 (2023) 2 - p. 389-403 , 2023

Link: https://doi.org/10.1158/..

7

A Dysfunctional T-cell Gene Signature for Predicting Nonres..:

Hummelink, Karlijn ; Tissier, Renaud ; Bosch, Linda J.W....
Clinical Cancer Research. 30 (2023) 4 - p. 814-823 , 2023

Link: https://doi.org/10.1158/..

8

European Epidemiology of Pleural Mesothelioma—Real-Life Dat..:

Opitz, Isabelle ; Bille, Andrea ; Dafni, Urania...
Journal of Thoracic Oncology. 18 (2023) 9 - p. 1233-1247 , 2023

Link: https://doi.org/10.1016/..

9

Impact of centralization of care for malignant peritoneal m..:

van Kooten, Job P. ; de Gooijer, Cornedine J. ; von der Thüsen, Jan H....
European Journal of Surgical Oncology. 49 (2023) 3 - p. 611-618 , 2023

Link: https://doi.org/10.1016/..

10

A phase 2 trial combining afatinib with cetuximab in patien..:

van Veggel, Bianca A. M. H. ; van der Wekken, Anthonie J. ; Paats, Marthe S....
Cancer. 130 (2023) 5 - p. 683-691 , 2023

Link: https://doi.org/10.1002/..

11

Persistent mutation burden drives sustained anti-tumor immu..:

Niknafs, Noushin ; Balan, Archana ; Cherry, Christopher...
Nature Medicine. 29 (2023) 2 - p. 440-449 , 2023

Link: https://doi.org/10.1038/..

12

Tobacco Smoking-Related Mutational Signatures in Classifyin..:

Ernst, Sophie M. ; Mankor, Joanne M. ; van Riet, Job...
Journal of Thoracic Oncology. 18 (2023) 4 - p. 487-498 , 2023

Link: https://doi.org/10.1016/..

13

Optimized whole-genome sequencing workflow for tumor diagno..:

Samsom, Kris G. ; Bosch, Linda J. W. ; Schipper, Luuk J....
Nature Protocols. 19 (2023) 3 - p. 700-726 , 2023

Link: https://doi.org/10.1038/..

14

A review on genetic alterations in CNS metastases related t..:

Wessels, Peter H. ; Boelens, Mirjam C. ; Monkhorst, Kim...
Journal of Neuro-Oncology. , 2023

Link: https://doi.org/10.1007/..

15

Pembrolizumab plus lenvatinib in second-line and third-line..:

Douma, Li-Anne H ; Lalezari, Ferry ; van der Noort, Vincent...
The Lancet Oncology. 24 (2023) 11 - p. 1219-1228 , 2023

Link: https://doi.org/10.1016/..

1-15